Biocon Biologics, a leading subsidiary of Biocon Ltd., has achieved a significant milestone with the U.S. Food and Drug Administration (USFDA) approval for its biosimilar version of Janssen's Stelara (Ustekinumab). This approval, granted under the rigorous 351(k) regulatory pathway, is poised to address the growing
Dr. Khalid Raza, an Associate Professor at Jamia Millia Islamia, has been awarded a prestigious research grant worth approximately ₹94 lakh by the Indian Council of Medical Research (ICMR). This grant supports groundbreaking research into leveraging Artificial Intelligence (AI) for enhancing breast cancer treatment. Focus of
Beurer India Pvt Ltd has unveiled the GL 22 Blood Glucose Monitor, a state-of-the-art device crafted under the "Make in India" initiative. This cutting-edge product was launched by cricket legend and Beurer India’s brand ambassador, Sourav Ganguly, highlighting the company’s commitment to blending German precision
India’s healthcare providers face significant challenges accessing affordable, high-quality medical equipment since the halt of refurbished medical device imports on August 15, 2024. The restriction, introduced by regulatory changes requiring clearance from the Central Drugs Standard Control Organisation (CDSCO) instead of the Ministry of Environment,
the global community marked World AIDS Day, an annual occasion dedicated to raising awareness about HIV/AIDS, reducing stigma, and remembering those affected by the epidemic. India commemorated the day with an event inaugurated by Union Health Minister Jagat Prakash Nadda at the Devi Ahilya Vishwavidyalaya
Dr. Swati Rajagopal, Consultant - Infectious Disease & Travel Medicine, Aster CMI Hospital, Bangalore Key updates on early diagnosis and treatment advancements of HIV/Aids in India? India has expanded early infant diagnosis (EID) programs and introduced point-of-care tools to detect HIV, particularly in newborns, though rural